Related Experiment Video
Updated: Feb 14, 2026

Robotic Cochlear Implantation for Direct Cochlear Access
Published on: June 16, 2022
Cochlear implantation in pediatric patients with Cockayne Syndrome
Renae D Van Wyhe1, Claudia V Emery2, Robert A Williamson3
1Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA; Texas Children's Hospital, Department of Pediatric Otolaryngology, 5th Floor, 6621 Fannin Street, Houston, TX 77030, USA.
Abstract:
Cockayne Syndrome (CS) is a rare, autosomal recessive disorder characterized by a spectrum of phenotypic abnormalities, including progressive sensorineural hearing loss (SNHL) that involves both peripheral and central components. To date, a single series of CS patients undergoing cochlear implant (CI) placement has been reported; this study reports on additional previously unreported pediatric CI recipients. Subjective benefits were noted early after activation in both patients, and speech perception scores improved over time as well, varying from 42 to 70% (versus 0-12% previously). Thus, we report that cochlear implantation in pediatric patients with CS can be effective in the management of progressive SNHL.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Nephrotic Syndrome I : Introduction
Acute Coronary Syndrome I: Introduction

